ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/09/2026
Back to search
Official data from USPTO
LINAFEXOR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
07/09/2026
Trademark type
Word
Nice classes
5
Filing date
10/11/2021
Registration date
06/27/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/27/2023
Last transaction
07/09/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
CN
Examiner
GAINES, LEAH R
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cascade Pharmaceuticals, Inc
Representatives
Geza C. Ziegler jr. ZIEGLER IP LAW GROUP LLC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of immuneinflammatory and metabolic diseasesnonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)cholestatic liver diseaseinflammatory bowel diseasechronic kidney disease for medical purposes; organotherapy preparations; enzyme preparations for medical purposes; medicines for the treatment of immuneinflammatory and metabolic diseasesnonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)cholestatic liver diseaseinflammatory bowel diseasechronic kidney diseasefor human purposes; chemical preparations for medical purposesnamely for immuneinflammatory and metabolic diseasesparticularlynonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)cholestatic liver diseaseinflammatory bowel diseasechronic kidney disease; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; the foregoing featuring farnesoid X receptor agonists
Publications
History of USPTO decisions and trademark events.
39 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/16/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/27/2023
FIMP
FINAL DISPOSITION PROCESSED
09/27/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/27/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/27/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/27/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/24/2023
GPNX
NOTIFICATION PROCESSED BY IB
04/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/11/2023
PUBO
PUBLISHED FOR OPPOSITION
04/11/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/05/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/22/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/22/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/03/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/30/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/30/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/30/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/30/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/30/2023
RFNT
REFUSAL PROCESSED BY IB
09/05/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/15/2022
RFRR
REFUSAL PROCESSED BY MPU
08/15/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/26/2022
CNRT
NON-FINAL ACTION WRITTEN
07/25/2022
DOCK
ASSIGNED TO EXAMINER
07/15/2022
MAFR
APPLICATION FILING RECEIPT MAILED
11/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/04/2021
Continuous trademark protection
Get notified about every new filing that threatens LINAFEXOR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.